|
 |
|
|||||||
|
|||||||||
Diabetes 54:1598-1602, 2005
© 2005 by the American Diabetes Association, Inc.
Brief Genetics Reports |
Variations in Peptide YY and Y2 Receptor Genes Are Associated With Severe Obesity in Pima Indian Men
From the Diabetes Molecular Genetics Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, Arizona
Peptide YY (PYY) and Y2 receptor (Y2R) may be important in the central regulation of body weight and food intake. To determine whether genetic variation in PYY and/or Y2R may contribute to morbid obesity in humans, these genes were sequenced in 83 extremely obese Pima Indians (BMI 
50 kg/m2). Sequencing of PYY identified three single nucleotide polymorphsms (SNPs) in the untranslated region. Sequencing of the Y2R coding region identified one missense (Ala172Thr) substitution and two silent substitutions. Eight additional SNPs in the 5' untranslated region of Y2R were identified from public databases. These SNPs were genotyped in 489 full-heritage adult Pimas (362 severely obese and 127 nondiabetic, nonobese subjects), who are not first-degree relatives, for association analysis. The PYY variants were not associated with obesity, whereas four variants from two haplotype blocks in Y2R were marginally associated (P = 0.054–0.067) with obesity. However, if the analysis was restricted to men (n = 167, 100 obese and 67 lean), the PYY variants and two SNPs in Y2R that were in complete linkage disequilibrium were significantly associated with severe obesity (P = 0.001 and P = 0.002, respectively). Our data suggest that the PYY-Y2R pathway may influence body weight through a sex-specific mechanism, but this finding requires confirmation in other populations.
Address correspondence and reprint requests to Leslie J. Baier PhD, Diabetes Molecular Genetics Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 4212 North 16th St., Phoenix, AZ 85016, E-mail: lbaier{at}phx.niddk.nih.gov
Abbreviations: NPY, neuropeptide Y; PYY, peptide YY; SNP, single nucleotide polymorphism; Y2R, Y2 receptor
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. Kamiji and A. Inui Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity Endocr. Rev., October 1, 2007; 28(6): 664 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Campbell, H. N. Lyon, J. Nemesh, J. A. Drake, T. Tuomi, D. Gaudet, X. Zhu, R. S. Cooper, K. G. Ardlie, L. C. Groop, et al. Association Studies of BMI and Type 2 Diabetes in the Neuropeptide Y Pathway: A Possible Role for NPY2R as a Candidate Gene for Type 2 Diabetes in Men Diabetes, May 1, 2007; 56(5): 1460 - 1467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hainerova, S. S. Torekov, J. Ek, M. Finkova, K. Borch-Johnsen, T. Jorgensen, O. D. Madsen, J. Lebl, T. Hansen, and O. Pedersen Association between Neuromedin U Gene Variants and Overweight and Obesity J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5057 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bacha and S. A. Arslanian Ghrelin and Peptide YY in Youth: Are There Race-Related Differences? J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3117 - 3122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ahituv, N. Kavaslar, W. Schackwitz, A. Ustaszewska, J. M. Collier, S. Hebert, H. Doelle, R. Dent, L. A. Pennacchio, and R. McPherson A PYY Q62P variant linked to human obesity Hum. Mol. Genet., February 1, 2006; 15(3): 387 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Roth, P. J. Enriori, K. Harz, J. Woelfle, M. A. Cowley, and T. Reinehr Peptide YY Is a Regulator of Energy Homeostasis in Obese Children before and after Weight Loss J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6386 - 6391. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |